Purification and HPLC-MS analysis of a naturally processed HCMV-derived peptide isolated from the HEK-293T/HLA-E+/Ul40+ cell transfectants and presented at the cell surface in the context of HLA-E

Journal of Immunological Methods

Volumn 322, Issue 1-2, 2007, Pages 128-136

  Millo, E ^a   Pietra, G ^a   Armirotti, A ^a   Vacca, P ^a   Mingari, M C ^a,c   Moretta, L ^a,b   Damonte, G ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Cytomegalovirus; High performance liquid chromatography; HLA E; mass spectrometry; Peptides

Indexed keywords

HLA ANTIGEN CLASS 1; HLA E ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; CELL ISOLATION; CELL SURFACE; CHROMATOGRAPHY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; ELECTROSPRAY MASS SPECTROMETRY; ENZYME PURIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HLA SYSTEM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROCESSING; TANDEM MASS SPECTROMETRY; VIRUS DETECTION;

AMINO ACID SEQUENCE; CELL MEMBRANE; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOMEGALOVIRUS; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDES; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TRANSFECTION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 34147123733     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2007.01.018     Document Type: Article

References (28)

1. Biemann K. Sequencing of peptides by tandem mass spectrometry and high-energy collision- induced dissociation. Methods Enzymol. 193 (1990) 886
2. Bijlmkers J., and Ploegh H.L. Putting together an MHC class I molecule. Curr. Opin. Immunol. 5 1 (1993) 21
3. Bonner P.L., Lill J.R., Hill S., Creaser C.S., and Rees R.C. Electrospray mass spectrometry for the identification of MHC class I-associated peptides expressed on cancer cells. J Immunol. Methods 262 (2002) 5
4. Clark R.E., Dodi A., Hill S.C., Lill J.R., Aubert G., Macintyre A.R., Rojas J., Bourdon A., Bonner P.L.R., Wang L., Christmas S.E., Travers P.E., Creaser C.S., Rees R.C., and Madrigal J.A. Direct evidence that leukaemic cells present HLA associated immunogenic peptides derived from the BCR-ABLb3a2 fusion protein. Blood 98 (2001) 2887
5. Falk K., Rotzschke O., Deres K., Metzger J., Jung G., and Rammensee H.G. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T-cell epitope forecast. J. Exp. Med. 174 (1991) 425
6. Garcia P., Llano M., de Heredia A.B., Willberg C.B., Caparros E., Aparicio P., Braud V.M., and Lopez-Botet M. Human T-cell receptor-mediated recognition of HLA-E. Eur. J. Immunol. 32 (2002) 936
7. Heinzel A.S., Grotzke J.E., Lines R.A., Lewinsohn D.A., McNabb A.L., Streblow D.N., Braud V.M., Grieser H.J., Belisle J.T., and Lewinsohn D.M. HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T-cells. J. Exp. Med. 196 (2002) 1473
8. Hofmann S., Gluckmann M., Kausche S., Schmidt A., Corvey C., Lichtenfels R., Huber C., Albrecht C., Karas M., and Herr W. Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS. Mol. Cell Proteomics. 4 12 (2005) 1888
9. Lemmel C., and Stevanovic S. The use of HPLC-MS in T-cell epitope identification. Methods. 29 (2003) 248
10. Li J., Goldstein I., Glickman-Nir E., Jiang H., and Chess L. Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E. J. Immunol. 167 (2001) 3800
11. Mingari M.C., Cambiaggi A., Vitale C., Schiavetti F., Bellomo R., and Poggi A. Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation. Int. Immunol. 8 (1996) 203
12. Ovsyannikova I.G., Johnson K.L., Naylor S., and Poland G.A. Identification of HLA-DRB1-bound self-peptides following measles virus infection B. J. Immunol. Methods 297 (2005) 153
13. *0201 epitope identified by mass spectrometry. Cancer Res. 61 (2001) 4072
14. Pietra G., Romagnani C., Falco M., Vitale M., Castriconi R., Pende D., Millo E., Anfossi S., Biassoni R., Moretta L., and Mingari M.C. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition. Eur J Immunol. 31 (2001) 3687
15. Pietra G., Romagnani C., Mazzarino P., Falco M., Millo E., Moretta A., Moretta L., and Mingari M.C. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic lymphocytes. Proc. Natl. Acad Sci .U. S. A. 100 19 (2003) 10896
16. Rammensee H.G., Falk K., and Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11 (1993) 213
17. Rock K.L., and Goldberg A.L. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17 (1999) 739
18. Rodgers J.R., and Cook R.C. MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 5 (2005) 459
19. Rohrlich P.S., Fazilleau N., Ginhoux F., Firat H., Michel F., Cochet M., Laham N., Roth M.P., Pascolo S., Nato F., Coppin H., Charneau P., Danos O., Acuto O., Ehrlich R., Kanellopoulos J., and Lemonnier F.A. Direct recognition by alphabeta cytolytic T-cells of Hfe, a MHC class Ib molecule without antigen-presenting function. Proc. Natl. Acad. Sci. U. S. A. 6,102 36 (2005) 12855
20. Rotzschke O., Falk K., Deres K., Schild H., Norda M., Metzger J., Jung G., and Rammensee H.G. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T-cells. Nature. 348 (1990) 252
21. Schirle M., Keilholz W., Weber B., Gouttefangeas C., Dumrese T., Becker H.D., Stevanovic S., and Rammensee H.G. Identification of tumor-associated MHC class I ligands by a novel T-cell-independent approach. Eur. J. Immunol. 30 8 (2000) 2216
22. Stam N.J., Vroom T.M., Peters P.J., Pastoors E.B., and Ploegh H.L. HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int. Immunol. 2 2 (1990) 113
23. Storkus W.J., Zeh III H.J., Salter R.D., and Lotze M.T. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J. Immunother. 14 2 (1993) 94
24. Storkus W.J., Zeh III H.J., Maeurer M.J., Salter R.D., and Lotze M.T. Identification of human melanoma peptides recognized by class bI restricted tumor infiltrating T lymphocytes. J. Immunol. 151 (1993) 3719
25. Townsend A., and Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7 (1989) 601
26. van der Heeft E., ten Hove G.J., Herberts C.A., Meiring H.D., van Els C.A.C.M., and de Jong A.P.J.M. Microcapillary column switching HPLC electrospray ionization MS system for the direct identification of peptides presented by major histocompatibility complex class I molecules. Anal. Chem. 70 (1998) 3742
27. *0201-associate peptide display and is mutated at its anchor position in persistent viral strains. Eur. J. Immunol. 30 (2000) 1172
28. Wellings D.A., and Atherton E. Standard Fmoc Protocols. Methods Enzimol. 289 (1997) 44